Increased serum and CFS levels of IL-6, an inflammatory cytokine having a pivotal role in enhancing and maintaining the inflammatory response and activating adaptive immunity, have been demonstrated in patients with refractory epilepsy (130, 131). The gene discussed is IL6; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.